Browsing: GLP1

The US drug watchdog FDA on Monday said the weight-loss drugs had been associated with non-arteritic anterior ischaemic optic neuropathy (NAION), a condition that can lead to sudden, painless loss of vision in one eye, including permanent vision loss.